Last reviewed · How we verify
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study (STOPDAPT-3)
The purpose of this study is to explore the benefit of the prasugrel monotherapy without aspirin as compared with the 1-month dual therapy with aspirin and prasugrel in terms of reducing bleeding events after percutaneous coronary intervention (PCI) using cobalt-chromium everolimus-eluting stents (CoCr-EES, XienceTM) in patients with high bleeding risk or under the acute coronary syndrome patients.
Details
| Lead sponsor | Kyoto University, Graduate School of Medicine |
|---|---|
| Phase | PHASE4 |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 6002 |
| Start date | Fri Jan 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Coronary Syndrome
Interventions
- No aspirin
- 1-month DAPT
Countries
Japan